Follow on Google News News By Tag * Chugai * Prescription * Pharmaceutical * 2003-09 * Pharmavitae * 2003-15 * Mab * Pharma * Molecule * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | New Market Study Published: Chugai Pharmaceutical Co., Ltd: PharmaVitae ProfileFast Market Research recommends "Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile" from Datamonitor, now available
Features and benefits * Gain insight into Chugai's strategic outlook across the next 6 years * Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source Highlights Strategic insight into the prospects for Chugai over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales. Your key questions answered * Benchmark Chugai's performance against key rivals in the prescription pharmaceutical sector * Assess the strong sales performance of the company's monoclonal antibody (MAb) franchise, positioning Chugai as the leading Japanese MAb player For more information or to purchase this report, go to: - http://www.fastmr.com/ Report Table of Contents: Executive Summary Key findings Prescription pharmaceutical sales and growth rate performance, 2003-15 Financial performance, 2003-15 Chugai: PharmaVitae forecasts at a glance Strategic insight Chugai dominates the Japanese MAb landscape SWOT analysis Strengths Weaknesses pportunities Threats ABOUT THIS PROFILE PharmaVitae Explorer database Chapter structure Quarterly news update Company introduction Company sales Company financials Key products and competitors Data sourcing Analyst consensus QUARTERLY NEWS UPDATE Latest prescription pharma product news Q1 2010 Q4 2009 Q3 2009 Q2 2009 Q1 2009 COMPANY INTRODUCTION Key findings Background Key corporate developments M&A history Consolidation into the Roche group in October 2002 Divestments since the Roche merger have promoted prescription pharmaceuticals focus Current corporate structure COMPANY SALES Key findings Prescription pharmaceutical sales and growth rate analysis, 2003-15 Product analysis Product analysis, 2003-09 Product analysis, 2009-15 Therapy area analysis Geographic analysis Launch/core/ Explanation of launch/core/ Launch analysis, 2009-15 Core analysis, 2009-15 Expiry analysis, 2009-15 Launch/core/ Molecule type analysis Externalization analysis COMPANY FINANCIALS Key findings Reconciliation between PharmaVitae- perating costs and profit analysis perating costs and profit analysis, 2003-09 perating cost ratio and profit margin analysis, 2003-09 perating cost ratio and profit margin analysis, 2009-15 perating costs and profit analysis, 2008-14 KEY PRODUCTS AND COMPETITORS Key findings verview ncology Herceptin Rituxan Neutrogin Tarceva Hematology Epogin R-744/Mircera Immunology & inflammation Infectious disease Tamiflu Pegasys Genitourinary Evista APPENDIX References Abbreviations Exchange rates About Datamonitor The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment. View more research from Datamonitor at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|